OOIR: Observatory of International Research

Papers

(The H4-Index of Eurointervention is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Supporting evidence for ST-segment elevation myocardial infarction from optical coherence tomography	216
Letter: ORBITA-2 trial design and rationale: what causes angina after PCI?	107
Thirty years of transradial coronary interventions	87
Intracoronary polarimetry of a honeycomb-like structure	87
In search of the “IDEAL” left main coronary stent and DAPT regimen	78
Deep learning for prediction of fractional flow reserve from resting coronary pressure curves	73
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement	70
Women and coronary artery disease: not just underrepresented and underdiagnosed, but also undertreated!	63
Impella – a treatment for all STEMI patients with cardiogenic shock? The effect of off-hours admission	58
Robotic-assisted percutaneous coronary intervention: the future or the past?	57
Real-world evidence with the ACURATE neo2: a prelude to the ACURATE IDE trial	54
Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged	52
Double-tap to treat paravalvular leak in high-risk annuli	50
Diagnostic accuracy of quantitative flow ratio in patients with arrhythmias	48
The patent foramen ovale does not spontaneously close in patients aged 60	46
Reply: Identifying vulnerable coronary atherosclerotic plaques: from theory to practice	45
Safety and efficiency of percutaneous coronary intervention using a standardised optical coherence tomography workflow	42
A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trial	41
ACURATE neo2: jack of all trades or master of none?	41
Mechanical thrombectomy for pulmonary embolism revisited: technological breakthrough or simple renovation?	39
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity	39
Clinical impact of intervention strategies after failed transcatheter mitral valve repair	39
Management of a giant dual-chamber pseudoaneurysm of the proximal left anterior descending artery	38
Targeting inflammation in atherosclerosis: overview, strategy and directions	38
In search of the origin of the acronym TAVI	37

Transcatheter heart valve thrombosis on the mitral stage: “The Tempest” or “Much Ado About Nothing”?	36
The POT-PUFF sign: an angiographic mark of stent malapposition during proximal optimisation	35
Transcatheter left ventriculoplasty	35
Outcomes of directional atherectomy for common femoral artery disease	34
Phasic flow patterns of right versus left coronary arteries in patients undergoing clinical physiological assessment	32
Reply: When is the optimal time point for detecting malapposition in coronary bifurcation trials?	31